US Stock MarketDetailed Quotes

CODX Co-diagnostics

Watchlist
  • 0.791
  • -0.004-0.50%
Close Jan 21 16:00 ET
25.26MMarket Cap-0.57P/E (TTM)

About Co-diagnostics Company

Co-Diagnostics, Inc. engages in the development and innovation of molecular tools for detection of infectious diseases, liquid biopsy for cancer screening, and agricultural applications. Its diagnostics systems enable very rapid, low-cost, molecular testing for organisms and genetic diseases by automating historically complex procedures in both the development and administration of tests. The company was founded by Brent C. Satterfield and Dwight Howard Egan on April 18, 2013 and is headquartered in Salt Lake City, UT.

Company Profile

SymbolCODX
Company NameCo-diagnostics
Listing DateJul 12, 2017
Issue Price6.00
Founded2013
CEOMr. Dwight H Egan
MarketNASDAQ
Employees155
Fiscal Year Ends12-31
Address2401 South Foothill Drive,Suite D
CitySalt Lake City
ProvinceUtah
CountryUnited States of America
Zip Code84109
Phone1-801-438-1036

Company Executives

  • Name
  • Position
  • Salary
  • Dwight H Egan
  • Chief Executive Officer and Chairman of the Board
  • 1.26M
  • Brian L. Brown
  • Secretary, Chief Financial Officer and Principal Accounting Officer
  • 1.04M
  • Richard Abbott
  • President
  • --
  • Richard S. Serbin
  • Independent Director
  • 298.00K
  • Dr. Eugene Durenard, Pd.D
  • Independent Director
  • 298.00K
  • James B. Nelson
  • Independent Director
  • 298.00K
  • Edward L. Murphy
  • Independent Director
  • 298.00K

Trending Stocks

Discussing
Trump 2.0 Era: What's the next opportunity in the markets?
▪️Could Trump's crypto policies potentially benefit the crypto market? ▪️Might his tariff policies have a positive effect on Chinese stocks Show More